Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.

Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- Access to the study record is blocked by a 403 Forbidden page, replacing the detailed study information with an error screen. The change removes visible study details, including the study description, contacts, and locations, preventing user access to enrollment and background information.SummaryDifference20%

- Check20 days agoChange DetectedUI copy changed from 'Find Contact Information' to 'Find contact information', and the revision label updated to v3.7.0 (replacing v3.6.6).SummaryDifference0.1%

- Check34 days agoChange DetectedThe page underwent a minor software revision, updating from v3.6.5 to v3.6.6. This update generally reflects backend or UI improvements without altering study content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now lists the Study Contact and Investigator details with direct contact information (jen.olson@alleviantmedical.com, +1 612 327 2741) and names of multiple investigators and sites. The recruitment status is shown as Recruiting with an updated 93-location site count, and several previously listed locations and the 'Enrolling by invitation' status were removed.SummaryDifference14%

- Check55 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's underlying template or rendering.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page.SummaryDifference0.0%

Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.